Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist (68)Ga-RM2 and (18)F-FDG in breast cancer samples

The Gastrin-Releasing Peptide Receptor (GRPR) is over-expressed in estrogen receptor (ER) positive breast tumors and related metastatic lymph nodes offering the opportunity of imaging and therapy of luminal tumors. (68)Ga-RM2 binding and (18)F-FDG binding in tumoral zones were measured and compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgat, Clément, Schollhammer, Romain, Macgrogan, Gaétan, Barthe, Nicole, Vélasco, Valérie, Vimont, Delphine, Cazeau, Anne-Laure, Fernandez, Philippe, Hindié, Elif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333408/
https://www.ncbi.nlm.nih.gov/pubmed/30645633
http://dx.doi.org/10.1371/journal.pone.0210905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333408/
https://www.ncbi.nlm.nih.gov/pubmed/30645633
http://dx.doi.org/10.1371/journal.pone.0210905

Ejemplares similares